# MoonLake Immunotherapeutics (MLTX) - Q4 2024 earnings

Reported February 26, 2025.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | $101.9K | Not available |
| EPS | $-0.72 | $-0.53 |

Earnings filing reader: [8-K 0001821586-25-000004](https://www.opencapital.sh/filings/0001821586-25-000004)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001821586-25-000004.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1821586/0001821586-25-000004-index.htm)
Periodic report: 10-K - https://www.sec.gov/Archives/edgar/data/1821586/0001821586-25-000006-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/mltx/earnings/q4-2024